Orion OyjORINF +4.81%100 Quick Ratio is 1.13 as of Mar. 2026, which is 29% below its 10-year median of 1.60. GuruFocus rates ORINF with a GF Score™ of 100/100 and a GF Value™ of $86.78. The stock has 2 warning signs investors should review. Among 997 Drug Manufacturers companies, Orion Oyj ranks worse than 60.88% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Orion Oyj's quick ratio for the quarter that ended in Mar. 2026 was 1.13.
Orion Oyj has a quick ratio of 1.13. It generally indicates good short-term financial strength.
The historical rank and industry rank for Orion Oyj's Quick Ratio or its related term are showing as below:
ORINF'
s Quick Ratio Range Over the Past 10 Years
Min: 1 Med: 1.6 Max: 2.5
Current: 1.13
During the past 13 years, Orion Oyj's highest Quick Ratio was 2.50. The lowest was 1.00. And the median was 1.60.
ORINF's Quick Ratio is ranked worse than 60.88% of 997
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs ORINF: 1.13
Orion Oyj (OTCPK:ORINF) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Orion Oyj Quick Ratio Related Terms
Orion Oyj Quick Ratio Historical Data
* Premium members only.
The historical data trend for Orion Oyj's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Orion Oyj's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Orion Oyj's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Orion Oyj's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orion Oyj (ORINF) has a Quick Ratio of 1.13 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Orion Oyj and its competitors. This is 29% below median its historical median of 1.60. Over the past decade, Orion Oyj's Quick Ratio has ranged from 1.00 to 2.50. According to the industry distribution chart, Orion Oyj ranks #607 out of 997 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is Orion Oyj's Quick Ratio too high?
Orion Oyj's current Quick Ratio of 1.13 is 29% below median its 10-year median of 1.60. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 2.50. The Drug Manufacturers industry median Quick Ratio is 1.45. Orion Oyj's value of 1.13 is 22.1% below this industry median. Based on the distribution chart, Orion Oyj ranks #607 out of 997 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Orion Oyj has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's Quick Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #607 out of 997 companies for Quick Ratio. This places Orion Oyj in the lower half of its industry. The industry median Quick Ratio is 1.45. Orion Oyj's value of 1.13 is 22.1% below this benchmark. Historically, Orion Oyj's own Quick Ratio has ranged from 1.00 to 2.50 over the past decade. While the company's 10-year median is 1.60 vs. the industry median of 1.45, Orion Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current Quick Ratio of 1.13 is 22.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current Quick Ratio is 1.13, which is 29% below median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current Quick Ratio of 1.13. The stock's GF Value™ is $86.78, compared to a current price of $82.75 — trading 4.6% below its estimated fair value. The current Quick Ratio is 1.13, which is 29% below median its 10-year median of 1.60 and 22.1% below the Drug Manufacturers industry median of 1.45. Orion Oyj's overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Orion Oyj (ORINF), the current Quick Ratio is 1.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be undervalued.
The current stock price of $82.75 is trading 4.6% below its estimated GF Value™ of $86.78.
Key valuation signals for ORINF:
Quick Ratio: 1.13 (29% below median its 10-year median of 1.60)
GF Value™: $86.78 vs. price of $82.75 (4.6% below fair value)
Industry Position: 22.1% below the Drug Manufacturers median (#607 of 997)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
100GF Score
Get the complete analysis for ORINF
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
